blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2129675

EP2129675 - DERIVATIVES OF IMIDAZO, PYRIMIDO AND DIAZEPINE PYRIMIDINE-DIONE, AND USE THEREOF AS A DRUG [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.01.2012
Database last updated on 19.10.2024
Most recent event   Tooltip13.01.2012Application deemed to be withdrawnpublished on 15.02.2012  [2012/07]
Applicant(s)For all designated states
IPSEN PHARMA S.A.S.
65, Quai Georges Gorse
92100 Boulogne-Billancourt / FR
[2009/50]
Inventor(s)01 / POITOUT, Lydie
3, avenue de la Providence
F-92160 Antony / FR
02 / BRAULT, Valérie
11, rue des Prêtres
F-78730 Saint-Arnoult-en-Yvelines / FR
 [2009/50]
Representative(s)Audonnet, Nathalie, et al
Ipsen Pharma
Direction Propriété Intellectuelle
65 quai Georges Gorse
92650 Boulogne Billancourt Cedex / FR
[N/P]
Former [2010/33]Audonnet, Nathalie, et al
Ipsen Pharma Direction Propriété Intellectuelle 65 quai Georges Gorse
92650 Boulogne Billancourt Cedex / FR
Former [2009/50]Bourgouin, André
IPSEN PHARMA S.A.S. 65, Quai Georges Gorse
92100 Boulogne-Billancourt / FR
Application number, filing date07872379.817.12.2007
[2009/50]
WO2007FR02090
Priority number, dateFR2006001100118.12.2006         Original published format: FR 0611001
[2009/50]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2008090286
Date:31.07.2008
Language:FR
[2008/31]
Type: A2 Application without search report 
No.:EP2129675
Date:09.12.2009
Language:FR
The application published by WIPO in one of the EPO official languages on 31.07.2008 takes the place of the publication of the European patent application.
[2009/50]
Search report(s)International search report - published on:EP18.09.2008
ClassificationIPC:C07D487/04, A61K31/519, A61P35/00, A61P25/00
[2009/50]
CPC:
C07D487/10 (EP,US); A61P25/00 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/28 (EP); A61P35/00 (EP);
C07D487/04 (EP,US); C07D495/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/50]
TitleGerman:DERIVATE VON IMIDAZO-, PYRIMIDO- UND DIAZEPIN-PYRIMIDIN-DION SOWIE DEREN VERWENDUNG ALS ARZNEIMITTEL[2009/50]
English:DERIVATIVES OF IMIDAZO, PYRIMIDO AND DIAZEPINE PYRIMIDINE-DIONE, AND USE THEREOF AS A DRUG[2009/50]
French:DÉRIVÉS D'IMIDAZO, PYRIMIDO ET DIAZÉPINE PYRIMIDINE-DIONE ET LEUR UTILISATION COMME MÉDICAMENT[2009/50]
Entry into regional phase20.07.2009National basic fee paid 
20.07.2009Designation fee(s) paid 
20.07.2009Examination fee paid 
Examination procedure20.07.2009Examination requested  [2009/50]
11.12.2009Despatch of a communication from the examining division (Time limit: M04)
09.04.2010Reply to a communication from the examining division
18.11.2010Despatch of a communication from the examining division (Time limit: M04)
14.01.2011Reply to a communication from the examining division
11.04.2011Communication of intention to grant the patent
23.08.2011Application deemed to be withdrawn, date of legal effect  [2012/07]
28.09.2011Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2012/07]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.12.2009
Fees paidRenewal fee
04.01.2010Renewal fee patent year 03
03.01.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0116948  (SYNTEX INC [US]) [A] 1-21 * page 5, ligne 14 à page 6, ligne 2; exemple 4; tableau 1; revendications 1, 16, 26-31, 35-40 *;
 [A]WO2005063762  (SQUIBB BRISTOL MYERS CO [US], et al) [A] 1,19-21 * claims 1-73 *;
 [A]  - BURBULIENE, MILDA M. ET AL, "Synthesis and intramolecular cyclization of 2-methylsulfanyl-4-oxo-3(4H)- quinazolinylacetohydrazide", JOURNAL OF HETEROCYCLIC CHEMISTRY , 43(1), 43-47 CODEN: JHTCAD; ISSN: 0022-152X, (200601), vol. 43, no. 1, pages 43 - 47, XP002444067 [A] 1 * page 1, colonne 1; shéma 2, composé 5; page 46 *

DOI:   http://dx.doi.org/10.1002/jhet.5570430106
by applicantWO2005063762
 EP0116948
    - J. HETEROCYCLIC CHEMISTRY, (10620), vol. 43, no. 1, pages 42 - 47
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.